JPRN-UMIN000002322已完成4 期
Administration time-dependent effects of raloxifen in postmenopausal women with osteoporosis - Chronotherapy of raloxifen
Division of Clinical Pharmacology, Department of Pharmacology, School of Medicine, Jichi Medical University0 个研究点目标入组 64 人开始时间: 2009年8月11日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Treatment with raloxifene or bisphosphonate in the preceding 12 months Anticoagulant therapy Inpatients Current or previous venous thromboembolism Bedridden subjects Antiphospholipid antibody syndrome Possibility of pregnancy Hypersensitivity to raloxifene Severe hepatic impairment Severe renal dysfunction Other unsuitableness
研究者
相似试验
进行中（未招募）
1 期
A randomized trial administering Raloxifene vs. Placebo as add-on to antipsychotics in post menopausal patients with schizophrenia or schizoaffecive disorderschizophrenia or schizoaffecive disorderEUCTR2010-023983-42-ROThe Stanley Medical Research Institute200
已完成
3 期
Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With OsteoporosisOsteoporosis, PostmenopausalNCT00670319Eli Lilly and Company7,705
已完成
不适用
clinical trial on the efficacy of Raloxifene on disease activity in Rheumatoid ArthritisRheumatoid Arthritis.Rheumatoid arthritis, unspecifiedIRCT2015052022334N1Research Chancellor of Mashhad University of Medical Sciences40
已完成
不适用
Effect of raloxifen on kidney function in post menopausal women with diabetic nephropathyDiabetic Nephropathy.E10, E11,IRCT138904151179N4Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences50
已完成
2 期
Raloxifene in the treatment of schizophreniaschizophreniaIRCT201205131556N42Tehran University of Medical Sciences46